Form D · Biotechnology
CAPRICOR INC
Los Angeles, CA · CIK 0001374952
Offering snapshot reported Apr 13, 2012 · SEC filing
- Reported sold
- $6M Offering amount: $15M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Jan 13, 2012 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,500,000 → $6,000,000
- Reported investors3 → 4
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 13, 2012 | Amendment | $6,000,000 | $1,500,000vs Jan 30, 2012 | 4 | SEC filing |
| Jan 30, 2012 | Initial | $4,500,000 | No comparison | 3 | SEC filing |
| Jul 28, 2010 | Amendment | $2,800,000 | $1,000,000vs Jun 15, 2010 | 7 | SEC filing |
| Jun 15, 2010 | Amendment | $1,800,000 | $1,000,000vs Jan 6, 2010 | 6 | SEC filing |
| Jan 6, 2010 | Amendment | $800,000 | $0vs Jan 6, 2010 | 5 | SEC filing |
| Jan 6, 2010 | Initial | $800,000 | No comparison | 5 | SEC filing |
| Sep 6, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-172633
Source: Form D, filed Apr 13, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Abraham | Executive |
| Earl M. Collier, Jr. | Director |
| Louis Grasmick | Director |
| Louis V. Manzo | Director |
| Eduardo Marban | Director, Promoter |
| Linda S. Marban | Director, Executive |
| Rachel Smith | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8700 Beverly Boulevard Davis 1099
Los Angeles, CA, 90048
Los Angeles, CA, 90048